Bond.az White LogoBond.az Black Logo

Southwest: Fare hikes don't impact demand

Southwest Airlines CEO Bob Jordan says demand remains strong despite seven fare increases since February. The airline plans more premium options and potential long-haul international flights.

Robert Moore
ByRobert Moore- Senior Editor
|
0

Bond.az reports: Southwest Airlines CEO Bob Jordan said on Wednesday the carrier has seen no drop-off in demand after joining seven industry fare increases since February, making him increasingly confident the airline can offset higher fuel costs with stronger revenue.

Speaking at a Bernstein investor conference, Jordan said the fare increases were the most he could recall in his 38 years in the industry. But demand remained strong across leisure and business travel, geographies and the booking curve.

“With fares up though that much, there’s been no drop-off in demand at all,” Jordan said. His comments add to signs that U.S. carriers are retaining pricing power even as a jump in jet fuel prices threatens to pressure margins, helped by strong premium and business demand and reduced discount-carrier competition.

Jordan also signaled Southwest could go further in reshaping its product, saying the airline may add more cabin options, including “true first class,” and is likely over time to delve into long-haul international flying. “I want to give you fewer and fewer reasons to book another airline,” Jordan said, while adding Southwest would remain focused on its domestic schedule, nonstop flights, operations, hospitality and employees.

Southwest has already introduced assigned seating, extra-legroom seats and other product changes. Business revenue rose 25% in March from a year earlier, with that trend continuing in April and May. Enrollment in Southwest’s Rapid Rewards loyalty program rose 37% in the first quarter.

More News
Today / 18:34
|
908

Anthropic Valued at $965 Billion After $65B Raise

Anthropic raises $65 billion in Series H funding at a $965 billion valuation, led by major investors including Amazon.

0
Today / 18:02
|
291

S&P, Nasdaq hit record highs on Iran deal hopes

S&P 500 and Nasdaq Composite hit new record highs. Hopes for a US-Iran peace deal and inflation data boosted markets.

0
Today / 17:33
|
718

Anthropic to launch Claude Mythos in coming weeks

Anthropic launches Claude Opus 4.8, with Mythos coming in weeks. Advanced cybersecurity AI raises concerns but shows improved honesty.

0
Today / 17:31
|
747

Agilent stock upgraded to Buy by BofA

Bank of America upgrades Agilent Technologies to Buy after strong quarterly results. New target $145.

0
Today / 17:03
|
310

Temu fined $232 million for EU rule breach

Temu fined $232 million by EU for breaching rules on illegal product sales. European Commission cites failure to assess risks under Digital Services Act.

0
Today / 16:04
|
411

Symbotic stock falls on insider selling activity

Symbotic shares dropped 8% due to insider sales by executives Todd Krasnow and James Kuffner.

0
Today / 16:03
|
427

Goldman Sachs M&A volumes near 2021 record

Goldman Sachs M&A volumes are approaching a 2021 record, driven by corporate activity. President John Waldron cites strong backlogs.

0
Today / 15:33
|
309

Meta Commits Additional Funding to Oversight Board

Meta commits additional funding to its Oversight Board through 2028. The board makes binding content moderation decisions.

0
Today / 15:30
|
705

Ciena stock may move 13% on June 4 earnings

Ciena stock may move 13% on June 4 earnings release. Options data shows the company often beats implied moves. Get the latest analysis on Bond.az.

0
Today / 15:05
|
276

TA 35 index drops 1.02% at close

TA 35 index fell 1.02% amid losses in financial, insurance and banking sectors. Next Vision and Elbit Systems were top gainers.

0
Today / 15:02
|
328

Norway stocks rise at close

Norway stocks closed higher Thursday; Oslo OBX up 0.33%. Gainers: Kongsberg Gruppen, TGS NOPEC, Subsea 7. Losers: Hafnia, Frontline, Hoegh Autoliners.

0
Today / 15:00
|
257

Barclays Starts Oncology Biotechs with Positive Outlook

Barclays initiates coverage of Alpha Tau Medical, Cellectis, Immunome, and Sutro Biopharma with Overweight ratings.

0
...
Southwest: Fare hikes don't impact demand | Bond.az